The IRA’s price controls discourage post-marketing research. The potential benefits from expanding access to the drug to patients with other diseases will be lost.

A 14-year-old killed in a crash early Sunday morning was a student at South Mecklenburg High School. Carrie Underwood performs acapella after technical glitch at inauguration

Evercore ISI raised the firm’s price target on CMS Energy (CMS) to $73 from $64 and keeps an In Line rating on the shares. The firm maintains a

Maharashtra minister and NCP leader Aditi Tatkare on Wednesday said the top leaders of the ruling Mahayuti will take a decision on the row within the ruling coalition over the appointment of district

CMS has released its official 2025 mission and priorities document outlining its roadmap for state survey agencies Monday.

Teva Pharmaceuticals is suing the Centers for Medicare & Medicaid Services (CMS) for its implementation of the drug price negotiation program under the Inflation Reduction Act (IRA). | A new lawsuit from a drug manufacturer,

The work of the Innovation Center has benefited from continuity across administrations; the path to further expanding value-based care and building a health system that works for people and providers requires extending this legacy of continuity into the next administration.

Alignment Healthcare is the latest Medicare Advantage (MA) insurer to accuse the Centers for Medicare & Medicaid Services (CMS) of wrongly calculating the company’s star rating scores. | Insurers, perhaps smelling blood in the water,

The Centers for Medicare and Medicaid Services (CMS) has included Ozempic among the next 15 drugs chosen for Medicare negotiation. The CMS listed Ozempic, Rybelsus and Wegovy — all forms of

The Biden administration’s last MA rule is a boon for insurers, though it remains to be seen how the incoming Trump administration might put its stamp on the regulation before it’s finalized this spring.

By establishing coding and separate payment for certain digital mental health devices, this group from CMS and the FDA hopes to improve access to care.

Nepal has announced a 36% hike in Mount Everest climbing permit fees, raising the cost from $11,000 to $15,000 for the first time in nearly a decade. Effective from September, the increase aims to address overtourism,